Document:

Form of 2007 Employee Stock Purchase Plan Offering Document

 Exhibit 10.28 
 JAZZ PHARMACEUTICALS, INC. 
 2007
EMPLOYEE STOCK PURCHASE PLAN 
 OFFERING
DOCUMENT 
 ADOPTED BY THE BOARD OF
DIRECTORS: MAY 1, 2007 
 In this document, capitalized terms not otherwise defined shall have the
same definitions of such terms as in the Jazz Pharmaceuticals, Inc. 2007 Employee Stock Purchase Plan. 
  

	1.	GRANT; OFFERING DATE. 

 (a) The Board hereby authorizes a series of Offerings pursuant to the terms of this Offering document. 
 (b) The first Offering hereunder (the “Initial Offering”) shall begin on the date the Common Stock is first offered to the public under a registration statement declared effective under the Securities Act and
shall end on May 31, 2009, unless terminated earlier as provided below. The Initial Offering shall consist of four (4) Purchase Periods, with the first Purchase Period ending on November 30, 2007, the second Purchase Period ending on
May 31, 2008, the third Purchase Period ending on November 30, 2008, and the fourth Purchase Period ending on May 31, 2009. 
 (c) After the Initial Offering commences, a concurrent Offering shall begin on December 1, 2007 and each June 1 and December 1 beginning in 2008 over the term of the Plan and shall be approximately twenty-four
(24) months in duration. Each Offering shall consist of four (4) Purchase Periods, each of which shall be approximately six (6) months in length ending on or about May 31 and November 30 each year. Except as provided below,
a Purchase Date is the last day of a Purchase Period or of an Offering, as the case may be. 
 (d) Notwithstanding the foregoing:
(i) if any Offering Date falls on a day that is not a Trading Day, then such Offering Date shall instead fall on the next subsequent Trading Day, and (ii) if any Purchase Date falls on a day that is not a Trading Day, then such Purchase
Date shall instead fall on the immediately preceding Trading Day. 
 (e) Prior to the commencement of any Offering, the Board may
change any or all terms of such Offering and any subsequent Offerings. The granting of Purchase Rights pursuant to each Offering hereunder shall occur on each respective Offering Date unless prior to such date (i) the Board determines that such
Offering shall not occur, or (ii) no shares of Common Stock remain available for issuance under the Plan in connection with the Offering. 
 (f) Notwithstanding anything in this Section 1 to the contrary, if the Fair Market Value of a share of Common Stock on any Purchase Date during an Offering is less than or equal to the Fair Market Value of a share of Common
Stock on the Offering Date for that Offering, then that Offering shall terminate immediately following the purchase of shares of Common Stock on such Purchase Date. Participants in the terminated Offering automatically shall be enrolled in the
Offering that commences immediately after such Purchase Date. 
  

 1. 

	2.	ELIGIBLE EMPLOYEES. 

 (a) Each Eligible Employee who has been an Employee for a continuous period of at least ten (10) days ending on the Offering Date of an Offering hereunder and is either (i) an employee of the Company; (ii) an employee
of a Related Corporation incorporated in the United States; or (iii) an employee of a Related Corporation that is not incorporated in the United States, provided that the Board has designated the employees of such Related Corporation as
eligible to participate in the Offering, shall be granted a Purchase Right on the Offering Date of such Offering. 
 (b) Each person
who first becomes an Eligible Employee during an Offering shall not be granted a Purchase Right under such Offering. 
 (c)
Notwithstanding the foregoing, the following Employees shall not be Eligible Employees or be granted Purchase Rights under an Offering: 
 (i) Employees whose customary employment is twenty (20) hours per week or less or five (5) months per calendar year or less; 
 (ii) five percent (5%) stockholders (including ownership through unexercised and/or unvested stock options) as described in Section 5(c) of the Plan; or 
 (iii) Employees in jurisdictions outside of the United States if, as of the Offering Date of the Offering, the grant of such Purchase Rights would
not be in compliance with the applicable laws of any jurisdiction in which the Employee resides or is employed. 
  

	3.	PURCHASE RIGHTS. 

 (a) Subject to the limitations herein and in the Plan, a Participant’s Purchase Right shall permit the purchase of the number of shares of Common Stock purchasable with up to fifteen percent (15%) of such Participant’s
Earnings paid during the period of such Offering beginning immediately after such Participant first commences participation; provided, however, that no Participant may have more than fifteen percent (15%) of such Participant’s
Earnings applied to purchase shares of Common Stock under all ongoing Offerings under the Plan and all other plans of the Company and Related Corporations that are intended to qualify as Employee Stock Purchase Plans. 
 (b) For Offerings hereunder, “Earnings” means the base compensation paid to a Participant, including all salary, wages
(including amounts elected to be deferred by such Participant, that would otherwise have been paid, under any cash or deferred arrangement or other deferred compensation program established by the Company or a Related Corporation), but excluding all
overtime pay, commissions, bonuses, and other remuneration paid directly to such Participant, profit sharing, the cost of employee benefits paid for by the Company or a Related Corporation, education or tuition reimbursements, imputed income arising
under any Company or Related Corporation group insurance or benefit program, traveling expenses, business and 

  

 2. 

 
moving expense reimbursements, income received in connection with stock options, contributions made by the Company or a Related Corporation under any
employee benefit plan, and similar items of compensation. 
 (c) Notwithstanding the foregoing, the maximum number of shares of Common
Stock that a Participant may purchase on any Purchase Date in an Offering shall be such number of shares as has a Fair Market Value (determined as of the Offering Date for such Offering) equal to (x) $25,000 multiplied by the number of calendar
years in which the Purchase Right under such Offering has been outstanding at any time, minus (y) the Fair Market Value of any other shares of Common Stock (determined as of the relevant Offering Date with respect to such shares) that, for
purposes of the limitation of Section 423(b)(8) of the Code, are attributed to any of such calendar years in which the Purchase Right is outstanding. The amount in clause (y) of the previous sentence shall be determined in accordance with
regulations applicable under Section 423(b)(8) of the Code based on (i) the number of shares previously purchased with respect to such calendar years pursuant to such Offering or any other Offering under the Plan, or pursuant to any other
Company or Related Corporation plans intended to qualify as Employee Stock Purchase Plans, and (ii) the number of shares subject to other Purchase Rights outstanding on the Offering Date for such Offering pursuant to the Plan or any other such
Company or Related Corporation Employee Stock Purchase Plan. 
 (d) The maximum aggregate number of shares of Common Stock available
to be purchased by all Participants under an Offering shall be the number of shares of Common Stock remaining available under the Plan on the Offering Date. If the aggregate purchase of shares of Common Stock upon exercise of Purchase Rights granted
under all concurrent Offerings would exceed the maximum aggregate number of shares available, the Board shall make a uniform and equitable allocation of the shares available. Any Contributions not applied to the purchase of available shares of
Common Stock shall be refunded to the Participants without interest. 
 (e) Notwithstanding the foregoing, the maximum number of shares
of Common Stock that may be purchased on any single Purchase Date by all Eligible Employees under all ongoing Offerings shall not exceed 150,000 shares. If the aggregate number of shares of Common Stock to be purchased upon the exercise of all
outstanding Purchase Rights on a single Purchase Date would exceed such limit, the Board shall make a uniform and equitable allocation of the shares available. Any Contributions not applied to the purchase of available shares of Common Stock shall
be refunded to the Participants without interest. 
  

	4.	PURCHASE PRICE. 

 The
purchase price of shares of Common Stock under the Offering shall be the lesser of: (i) eighty-five percent (85%) of the Fair Market Value of such shares of Common Stock on the Offering Date, or (ii) eighty-five percent (85%) of
the Fair Market Value of such shares of Common Stock on the applicable Purchase Date. For the Initial Offering, the Fair Market Value of the shares of Common Stock at the time when the Offering commences shall be the price per share at which shares
are first sold to the public in the Company’s initial public offering as specified in the final prospectus for that initial public offering. 
  

 3. 

	5.	PARTICIPATION. 

 (a) An
Eligible Employee may elect to participate in an Offering on the Offering Date. An Eligible Employee may enroll in only one Offering at a time. An Eligible Employee shall elect his or her payroll deduction percentage on such enrollment form as the
Company provides. The completed enrollment form must be delivered to the Company at least five (5) days prior to the date participation is to be effective, unless a later time for filing the enrollment form is set by the Company for all
Eligible Employees with respect to a given Offering. Payroll deduction percentages must be expressed in whole percentages of Earnings, with a minimum percentage of one percent (1%) and a maximum percentage of fifteen percent (15%). Except as
provided in Section 5(e), a Participant may participate only by way of payroll deductions. 
 (b) A Participant may increase his
or her participation level once during a Purchase Period. In addition, a Participant may decrease (including a decrease to zero percent (0%)) his or her participation level no more than twice during a Purchase Period (and the second decrease in
participation level must be to zero percent (0%)). Any such change in participation level shall be made by delivering a notice to the Company or a designated Related Corporation, in such form as the Company may provide at least ten (10) days
(or such shorter period of time as determined by the Company and communicated to Participants) prior to the payroll date for which it is to be effective. A Participant may also increase his or her participation level effective in a subsequent
Purchase Period. 
 (c) A Participant may withdraw from an Offering and receive a refund of his or her Contributions (reduced to the
extent, if any, such Contributions have been used to acquire shares of Common Stock for the Participant on any prior Purchase Date) without interest, at any time prior to the end of the Offering, excluding the ten (10)-day period immediately
preceding a Purchase Date (or such shorter period of time determined by the Company and communicated to Participants), by delivering a withdrawal notice to the Company or a designated Related Corporation in such form as the Company may provide. A
Participant who has withdrawn from an Offering shall not again participate in such Offering, but may participate in subsequent Offerings under the Plan in accordance with the terms of the Plan and the terms of such subsequent Offerings. 

(d) Notwithstanding the foregoing or any other provision of this Offering document or of the Plan to the contrary, neither the enrollment of
any Eligible Employee in the Plan nor any forms relating to participation in the Plan shall be given effect until such time as a registration statement covering the shares reserved under the Plan that are subject to the Offering has been filed by
the Company and has become effective. 
 (e) If the provisions of Section 5(d) are applicable, the Company shall establish such
procedures as will enable the purposes of the Plan to be satisfied while complying with applicable securities laws. Such procedures may include, for example, allowing Participants to participate other than by means of payroll deduction and/or
allowing Participants to increase their level of participation during a Purchase Period. Except as otherwise provided by the Company pursuant to the preceding sentence, for the initial Purchase Period ending November 30, 2007, no payroll
deductions shall be required from the Eligible Employee until such time as the Eligible Employee affirmatively elects to commence such payroll deductions following the 

  

 4. 

 
Eligible Employee’s receipt of the Securities Act prospectus for the Plan. Each Eligible Employee shall automatically be enrolled in such initial
Purchase Period with a contribution rate equal to fifteen percent (15%) of Earnings and will have a limited opportunity to make all or part of the contributions in a lump sum payment, rather than through payroll deductions, prior to the end of
the initial Purchase Period. To the extent that the Eligible Employee’s payroll deductions for such initial Purchase Period are less than fifteen percent (15%) of Earnings paid to the Eligible Employee during such initial Purchase Period,
the Eligible Employee may make an additional cash payment at any time on or prior to November 20, 2007 in order to fund the purchase of shares of Common Stock purchased on behalf of the Eligible Employee on such initial Purchase Date.

  

	6.	PURCHASES. 

 Subject to the
limitations contained herein, on each Purchase Date, each Participant’s Contributions (without any increase for interest) shall be applied to the purchase of whole shares, up to the maximum number of shares permitted under the Plan and the
Offering. 
  

	7.	NOTICES AND AGREEMENTS. 

 Any notices or agreements provided for in an Offering or the Plan shall be given in writing, in a form provided by the Company (including documents delivered in electronic form, if authorized by the Committee), and
unless specifically provided for in the Plan or this Offering, shall be deemed effectively given upon receipt or, in the case of notices and agreements delivered by the Company, five (5) days after deposit in the United States mail, postage
prepaid. 
  

	8.	EXERCISE CONTINGENT ON STOCKHOLDER APPROVAL. 

 The Purchase Rights granted under an Offering are subject to the approval of the Plan by the stockholders of the Company as required for the Plan to
obtain treatment as an Employee Stock Purchase Plan. 
  

	9.	OFFERING SUBJECT TO PLAN. 

 Each Offering is subject to all the provisions of the Plan, and the provisions of the Plan are hereby made a part of the Offering. The Offering is further
subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of an Offering and those of the Plan (including
interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan), the provisions of the Plan shall control. 
 * * * * 
  

 5.Directors Deferred Compensation Plan

 Exhibit 10.55 
 JAZZ PHARMACEUTICALS, INC. 
 DIRECTORS
DEFERRED COMPENSATION PLAN 
 APPROVED BY THE
BOARD: MAY 1, 2007 
 ARTICLE I 
 DEFINITIONS 
 1.1 “Board” shall mean the Board of
Directors of the Company. 
 1.2 “Change in Control” means any of the following: (a) the date that any
one person or persons acting as a group acquires ownership of Company stock constituting more than fifty percent (50%) of the total fair market value or total voting power of the stock of the Company; (b) the date that any one person or
persons acting as a group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or persons) ownership of the stock of the Company possessing fifty percent (50%) or more of the
total voting power of the stock of the Company; (c) the date that a majority of members of the Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board
before the date of the appointment or election; or (d) the date that any one person or persons acting as a group acquires assets (or has acquired during the 12-month period ending on the date of the most recent acquisition by such person or
persons) from the Company that have a total gross fair market value equal to or more than eighty percent (80%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. The
determination of whether an event constitutes a Change of Control for purposes of this Plan shall be made in accordance with its definition under Section 409A of the Code and the regulations and other guidance thereunder, and shall not involve
the exercise of any discretionary authority by the Board. 
 1.3 “Code” shall mean the Internal Revenue Code
of 1986, as amended. 
 1.4 “Common Stock” shall mean the common stock of the Company. 
 1.5 “Company” means Jazz Pharmaceuticals, Inc., a Delaware corporation. 
 1.6 “Director” shall mean a member of the Board who is not an employee of the Company or any of its subsidiaries.

 1.7 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 1.8 “Fair Market Value Per Share” shall mean the Market Value Per Share, or, if there has been no Public Offering, the
fair market value of the Common Stock as determined in the good faith discretion of the Board. 
 1.9 “Fees”
shall mean amounts earned for serving as a member of the Board, including any committees of the Board. 
  

 1. 

 1.10 “He”, “Him”, or “His”
shall apply equally to male and female members of the Board. 
 1.11 “Market Value Per Share” shall mean, for
any given day, the price per share equal to (i) the last sale price of the Common Stock on the such day on the principal stock exchange on which the Common Stock may at the time be listed or, (ii) if there shall have been no sales on such
exchange on such day, the average of the closing bid and asked prices of the Common Stock on such exchange on such day or, (iii) if there is no such bid and asked price on such day, the average of the closing bid and asked prices of the Common
Stock on the next preceding date when such bid and asked price occurred or, (iv) if the Common Stock shall not be so listed, the closing sales price of the Common Stock as reported by NASDAQ on such day in the over-the-counter market.

 1.12 “Plan” shall mean the Jazz Pharmaceuticals, Inc. Directors Deferred Compensation Plan for Directors,
as it may be amended from time to time. 
 1.13 “Public Offering” shall mean the sale of shares of Common
Stock to the public subsequent to the date hereof pursuant to a registration statement under the Securities Act of 1933, as amended, and the rules and regulations in effect thereunder, which has been declared effective by the Securities Exchange
Commission (other than a registration statement on Form S-4, Form S-8 or any other similar form). 
 1.14 “Stock
Account” shall mean the account created by the Company pursuant to Article III of this Plan in accordance with an election by a Director to receive stock compensation under Article II hereof. 
 1.15 “Year” shall mean a calendar year. 
 ARTICLE II 
 ELECTION TO DEFER 
 2.1 This Plan shall become effective on the date of the underwriting agreement between the Company and the underwriter(s) managing the initial
public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering. 
 2.2 A Director
may elect, on or before December 15 of any Year, to defer payment of all or a specified part of all Fees to be earned during the Year following the Year in which such election occurs and succeeding Years (until the Director ceases to be a
Director or changes his election pursuant to Section 2.4 herein); provided, however, that with respect to the first Year in which a Director becomes eligible to participate in the Plan, the Director may make an initial election within
thirty (30) days after the date the Director becomes so eligible to defer payment of all or a specified part of such Fees earned following the date on which such initial election is made during the remainder of such Year and for any succeeding
Years. 
 2.3 The election to participate in the Plan and manner of payment shall be designated by submitting a letter in the form
attached hereto as Appendix A to the Secretary of the Company. 
  

 2. 

 2.4 The election shall continue from Year to Year and become irrevocable on December 15 of
each Year, unless the Director changes or terminates it by written request delivered to the Secretary of the Company prior to December 15 of the Year preceding the commencement of the Year for which the changes or termination is first
effective. 
 ARTICLE III 
 DEFERRED COMPENSATION ACCOUNTS 
 3.1 The Company shall maintain separate memorandum accounts for the Fees deferred by
each Director. 
 3.2 The Company shall credit, on the date Fees become payable, the Stock Account of each Director with a number of
shares of Common Stock which is equal to the deferred portion of any Fee due the Director as to which an election to defer Fees into the Stock Account has been made, divided by the Fair Market Value Per Share determined as of the date such Fees
would otherwise have been paid. 
 3.3 The Company shall credit the Stock Account of each Director who has elected to receive deferred
compensation in the form of Common Stock with the number of shares of Common Stock equal to any cash dividends (or the fair market value of dividends paid in property other than dividends payable in Common Stock) payable on the number of shares of
Common Stock represented in each Director’s Stock Account, divided by the Fair Market Value Per Share on the applicable dividend payment date. Dividends payable in Common Stock will be credited to each Director’s Stock Account in the form
of the right to receive Common Stock. If adjustments are made to the outstanding shares Common Stock as a result of split-ups, recapitalizations, mergers, consolidations and the like, an appropriate adjustment also will be made in the number of
shares of Common Stock credited to the Director’s Stock Account. 
 3.4 Common Stock shall be computed to three decimal places.

 3.5 The right to receive Common Stock at a later date shall not entitle any person to rights of a stockholder with respect to such
Common Stock unless and until shares of Common Stock have been issued to such person pursuant to Article IV hereof. 
 3.6 The Stock
Account of a Director shall only be a bookkeeping account, and the Company shall not be required to acquire, reserve, segregate, or otherwise set aside shares of its Common Stock for the payment of its obligations under the Plan. The Company shall
make available as and when required a sufficient number of shares of its Common Stock to meet the needs of the Plan. 
 3.7 Nothing
contained herein shall be deemed to create a trust of any kind or any fiduciary relationship. To the extent that any person acquires a right to receive payments from the Company under the Plan, such right shall be no greater than the right of any
unsecured general creditor of the Company. 
  

 3. 

 ARTICLE IV 
 PAYMENT OF DEFERRED COMPENSATION 
 4.1 Subject to the other provisions of this Article IV,
amounts credited to a Director’s Stock Account shall be distributed as the Director’s election (made pursuant to Paragraph 2.2 of Article II hereof) shall provide. Distributions in respect of the Director’s Stock Account shall be paid
in cash or Common Stock, as the Director shall be permitted to elect at the time such account is to be distributed, and any such distributions shall begin on the tenth (10th) business day following the day on which a Director separates from
service with the Board. Shares of Common Stock available for distribution shall be funded with shares reserved under the Company’s 2007 Non-Employee Directors Stock Option Plan. Notwithstanding a Director’s election, to the extent that an
insufficient number of shares remains available under the Company’s 2007 Non-Employee Directors Stock Option Plan to fund distributions under the Plan, the Director’s Stock Account shall be paid in cash. 
 4.2 Each Director shall have the right to designate one or more beneficiaries to succeed to his right to receive payments hereunder in the event
of his death. Each designated beneficiary shall receive payments in the same manner as the Director if he had lived. In case of a failure of designation or the death of all designated beneficiaries without any designated successors, the balance of
the amounts credited to the Director’s Stock Account shall be payable in accordance with Section 4.1 to the Director’s or former Director’s estate in full on the first day of the Year following the Year in which he dies. No
beneficiary designation shall be valid unless it is in writing, signed by the Director and filed with the Secretary of the Company. 
 4.3
In the event of a Change in Control, (i) all amounts credited to each Director’s Stock Account shall be distributed on the tenth (10th) business day after the occurrence of such Change in Control and (ii) any Director who
elects to have his or her Stock Account distributed in shares of Common Stock must notify the Company of such election in writing no later than the fifth (5th) business day prior to the Change in Control. 
 4.4 In the event that a Director elects to have a distribution in cash in respect of his or her Stock Account, the total amount of cash to be paid
shall be determined by multiplying the number of shares of Common Stock credited to such account on the last business day prior to the date that the first distribution of such account is to be made, by the then Fair Market Value Per Share.

 ARTICLE V 
 ADMINISTRATION 
 5.1 The Company shall administer the Plan at its expense. All decisions made by the Company with
respect to issues hereunder shall be final and binding on all parties. 
 5.2 Except to the extent required by law, the right of any
Director or any beneficiary to any benefit or to any payment hereunder shall not be subject in any manner to attachment or other legal process for the debts of such Director or beneficiary; and any such benefit or payment shall not be subject to
alienation, sale, transfer, assignment or encumbrance. 
  

 4. 

 ARTICLE VI 
 AMENDMENT OF PLAN; GOVERNING LAW; SECTION 409A. 
 6.1 The Plan may be amended, suspended or
terminated in whole or in part from time to time by the Board except that no amendment, suspension, or termination shall apply to the payment of any amounts previously credited to a Director’s Stock Account. 
 6.2 The Plan shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, without regard to principles of
conflict of law. 
 6.3 Notwithstanding any other provision of the Plan, this Plan is intended to comply with Section 409A and
shall at all times be interpreted in accordance with such intent such that amounts credited to Directors’ accounts shall not be taxable to Directors until such amounts are paid to Directors in accordance with the terms of the Plan. In
furtherance thereof, no payments may be accelerated under the Plan other than to the extent permitted under Section 409A of the Code (“Section 409A”). To the extent that any provision of the Plan violates
Section 409A such that amounts would be taxable to a Director prior to payment or would otherwise subject a Director to a penalty tax under Section 409A, such provision shall be automatically reformed or stricken to preserve the intent
hereof. To the extent that the Company determines that Directors may be given greater flexibility to modify or revoke deferral elections under the Plan in a manner consistent with Section 409A (based on future guidance promulgated by the
Internal Revenue Service and the Treasury Department from time to time), the Company may (but shall not be obligated to) amend the Plan to provide for such greater flexibility. 
  

 5. 

 APPENDIX A 
 [Date] 
 Jazz Pharmaceuticals, Inc. 
 3180 Porter Drive 
 Palo Alto, CA 94304 
 Dear [NAME]:

 Pursuant to the Jazz Pharmaceuticals, Inc. Directors Deferred Compensation Plan, adopted on May 1, 2007 (the
“Plan”), I hereby elect to defer receipt of all or a portion of my Director’s fees to which I may become entitled to receive in respect of 2007 and succeeding Years (unless and until I change my election for fees
receivable in succeeding years pursuant to the terms of the Plan) in accordance with the percentages indicated below. 
 Initial
Deferral Election. I hereby elect to have my director’s fees (and committee fees, if any) credited as follows (fill in appropriate percentages for options a, b and c below): 
  

	 	(a)	        % of the aggregate fees shall be credited to my Stock Account as provided for in the Plan; or 

 

	 	(b)	        % of the aggregate fees shall not be deferred, but shall be paid to me directly and promptly as they accrue.

 Timing of Distributions. I understand that my Stock Account shall each become payable on the earlier to occur
of the tenth (10th) business day following (i) the date of my separation from service with the Board and (ii) a Change in Control (as such term is defined in the Plan). 
 Manner of Distributions. Further, I elect to receive the payments pursuant to the Plan (check one desired method below): 
  

	 	(a)	If a distribution results due to my separation from service with the Board: in one lump sum; in (insert number) equal annual installments. 

  

	 	(b)	If a distribution results due to a Change in Control: in one lump sum; in (insert number) equal annual installments. 

  

	
	Very truly yours,
	
	[Name]

  

 6. 

 DESIGNATION OF BENEFICIARY 
 JAZZ PHARMACEUTICALS, INC. 
 DIRECTORS DEFERRED COMPENSATION PLAN 
 In
the event of my death prior to receipt of all or any amount of the balance of my Stock Account so accumulated, I designate the following one or more individuals
                                        
                                        
                     as my beneficiary or beneficiaries to receive the funds so accumulated, but unpaid. 
 Signed this             day of
                , 20    . 
  

	
	  

	[NAME]

 Witnessed this              day of
                , 20    . 
  

	
	  

	[WITNESS]

  

 7.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]